| HPV-associated oropharyngeal cancer: Epidemiology, molecular biology and clinical management M Lechner, J Liu, L Masterson, TR Fenton Nature Reviews Clinical Oncology 19 (5), 306-327, 2022 | 141 | 2022 |
| Anosmia as a presenting symptom of SARS-CoV-2 infection in healthcare workers–a systematic review of the literature, case series, and recommendations for clinical assessment … M Lechner, D Chandrasekharan, K Jumani, J Liu, S Gane, VJ Lund, ... Rhinology 58 (4), 394-399, 2020 | 60 | 2020 |
| Loss of smell and taste: a new marker of COVID-19? Tracking reduced sense of smell during the coronavirus pandemic using search trends G Cherry, J Rocke, M Chu, J Liu, M Lechner, VJ Lund, BN Kumar Expert Review of Anti-infective Therapy 18 (11), 1165-1170, 2020 | 47 | 2020 |
| Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy M Lechner, VH Schartinger, CD Steele, WL Nei, ML Ooft, LM Schreiber, ... Nature communications 12 (1), 1-11, 2021 | 25 | 2021 |
| A pan-tissue DNA methylation atlas enables in silico decomposition of human tissue methylomes at cell-type resolution T Zhu, J Liu, S Beck, S Pan, D Capper, M Lechner, C Thirlwell, CE Breeze, ... Nature Methods 19 (3), 296-306, 2022 | 23 | 2022 |
| Course of symptoms for loss of sense of smell and taste over time in one thousand forty‐one healthcare workers during the Covid‐19 pandemic: Our experience M Lechner, J Liu, N Counsell, NH Ta, J Rocke, R Anmolsingh, ... Clinical Otolaryngology 46 (2), 451, 2021 | 20 | 2021 |
| Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma M Lechner, Y Takahashi, M Turri-Zanoni, J Liu, N Counsell, M Hermsen, ... European Journal of Cancer 162, 221-236, 2022 | 17 | 2022 |
| Risk factors and characteristics associated with persistent smell loss in coronavirus disease 2019 (COVID‐19) patients B Shahrvini, DP Prajapati, M Said, J Liu, S Srinivas, S Jayaraj, VJ Lund, ... International forum of allergy & rhinology, 2021 | 10 | 2021 |
| Novel biomarkers in sinonasal cancers: from bench to bedside M Lechner, J Liu, VJ Lund Current Oncology Reports 22 (10), 1-10, 2020 | 10 | 2020 |
| Anosmia and hyposmia in health-care workers with undiagnosed SARS-CoV-2 infection M Lechner, N Counsell, J Liu, N Eynon-Lewis, S Paun, VJ Lund, S Jayaraj, ... The Lancet Microbe 1 (4), 2020 | 10 | 2020 |
| The COVANOS trial–insight into post-COVID olfactory dysfunction and the role of smell training M Lechner, J Liu, N Counsell, DC Gillespie, D Chandrasekharan, ... Rhinology 60 (3), 188-199, 2022 | 9 | 2022 |
| Copper-mediated anomeric O-arylation with organoboron reagents V Dimakos, JJW Liu, Z Ge, MS Taylor Organic & biomolecular chemistry 17 (23), 5671-5674, 2019 | 5 | 2019 |
| SSTR2 in Nasopharyngeal Carcinoma: Relationship with Latent EBV Infection and Potential as a Therapeutic Target O Emanuel, J Liu, VH Schartinger, WL Nei, YY Chan, CM Tsang, ... Cancers 13 (19), 4944, 2021 | 4 | 2021 |
| Reply to ‘HPV-associated oropharyngeal cancer—discussion points’ M Lechner, J Liu, L Masterson, TR Fenton Nature Reviews Clinical Oncology, 1-1, 2022 | | 2022 |
| Multicenter Analysis of Clinical Outcomes of Sinonasal Mucosal Melanoma M Lechner, Y Takahashi, M Turri-Zanoni, M Ferrari, J Liu, N Counsell, ... Journal of Neurological Surgery Part B: Skull Base 83 (S 01), A214, 2022 | | 2022 |
| Multicenter Study on Clinical Outcomes of Olfactory Neuroblastoma M Lechner, Y Takahashi, M Hermsen, M Turri-Zanoni, V Schartinger, ... Journal of Neurological Surgery Part B: Skull Base 82 (S 02), S043, 2021 | | 2021 |
